RPP Group

We're #hiring a new Office Manager in Brussels Region. Apply today or share this post with your network.

🌟 𝐒𝐭𝐚𝐲 𝐀𝐡𝐞𝐚𝐝 𝐨𝐟 𝐭𝐡𝐞 𝐂𝐮𝐫𝐯𝐞 𝐢𝐧 𝟐𝟎𝟐𝟓 🌟 ⁉️ Have you subscribed to the RPP Review yet? Our monthly newsletter provides analyses, impact assessments, and key insights into the rapidly changing political and health landscape across Europe. In the December edition, we explored the major political shifts and opportunities shaping 2025. 👇 Don't miss out—subscribe now to stay informed and prepared for the year ahead! https://lnkd.in/dKuvMW-p #Politics #Health #RPPReview

𝐒𝐭𝐚𝐭𝐞 𝐨𝐟 𝐏𝐥𝐚𝐲: 𝐈𝐭𝐚𝐥𝐲’𝐬 𝟐𝟎𝟐𝟓 𝐁𝐮𝐝𝐠𝐞𝐭 𝐋𝐚𝐰 𝐚𝐧𝐝 𝐈𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 🗳️ The amendments to Italy’s Budget Law introduce several updates to the country’s healthcare system, addressing key areas such as funding, governance, and innovation. 💡 Highlights include increased resources for the National Health Service (SSN), enhanced roles for patient associations, investments in innovative medicines and pandemic preparedness, and new governance measures for medical devices through the National Health Technology Assessment (HTA) Program. ✅ These measures aim to address regional disparities, advance precision medicine, strengthen the healthcare framework, and improve medical device management while balancing fiscal and operational challenges. 🌐 Explore the key healthcare measures and their potential impact in our latest blog article. 📩 For more information, feel free to reach out to Arianna Maviglia 👉 https://lnkd.in/eR6UGf2t #ItalyPolitics #HealthcarePolicy #BudgetLaw2025 #PublicHealth #HealthInnovation #MedicalDevices #Governance +++++++++ 𝐋𝐞𝐠𝐠𝐞 𝐝𝐢 𝐁𝐢𝐥𝐚𝐧𝐜𝐢𝐨 𝟐𝟎𝟐𝟓: 𝐈𝐦𝐩𝐥𝐢𝐜𝐚𝐳𝐢𝐨𝐧𝐢 𝐩𝐞𝐫 𝐥𝐚 𝐒𝐚𝐧𝐢𝐭à 🗳️ Le modifiche alla Legge di Bilancio 2025 introducono diverse novità nel sistema sanitario italiano, affrontando temi cruciali come finanziamenti, governance e innovazione. 💡 Tra i punti principali: maggiori risorse per il SSN, un ruolo ampliato per le associazioni di pazienti, investimenti in farmaci innovativi e preparazione pandemica, e nuove misure di governance per i dispositivi medici attraverso il Programma Nazionale di Health Technology Assessment (HTA). ✅ Questi interventi mirano a ridurre le disparità regionali, promuovere la medicina di precisione, rafforzare il sistema sanitario e migliorare la gestione dei dispositivi medici, affrontando sfide fiscali e operative. 🌐 Approfondisci i principali provvedimenti sanitari e le loro potenziali implicazioni nel nostro ultimo articolo del blog. 📩 Per ulteriori informazioni, contatta Arianna Maviglia. 👉 https://lnkd.in/eR6UGf2t #ItaliaPolitica #SanitàPubblica #LeggeDiBilancio2025 #InnovazioneSanitaria #DispositiviMedici #Governance

🎄✨ Here’s a snapshot of our Christmas celebrations across RPP’s offices - We are #OneRPP!   As we wrap up 2024, we want to take a moment to wish everyone in our network – especially our clients, valued stakeholders, and policymakers – a wonderful start to 2025. May the new year bring us the energy and drive to put health at the forefront of the political agenda for the next five years. Let’s continue to turn our impactful advocacy into action and make a real difference! 🌍💪   #RPPGroup #HealthPolicy #Advocacy #2025Goals #PuttingHealthFirst

We're #hiring a new Junior Associate in Brussels Region. Apply today or share this post with your network.

🌟 The RPP Spain team is taking a break, but not without leaving you a gift! 🌟 Before we disconnect and recharge during the holidays, we’re excited to share with you our 2024-2025 Healthcare Policy Report. This comprehensive analysis, crafted with care, includes: 📌 Key regulatory and political milestones in national healthcare for 2024 📌 2025 perspectives, focusing on innovation and sustainability 📌 In-depth insights into critical areas such as cardiovascular health, oncology, and antimicrobial resistance (AMR) 📌 Regional briefing for selected Autonomous Communities If you’re interested in diving deeper into any of these trends or want to explore how these strategies could impact your work, we’d be delighted to assist you. We’re here to answer your questions and collaborate on new challenges! 👉 Get in touch with us: Cristina Fuentes Antrás: c.fuentes@rpp-group.com Lutz Dommel: l.dommel@rpp-group.com Kit Greenop: k.greenop@rpp-group.com. 📥 Download the report and let’s prepare to shape the future of healthcare together! #RPPGroup #HealthcarePolicy #Innovation #Regulation #Holidays

🚨 𝐒𝐭𝐚𝐭𝐞 𝐨𝐟 𝐏𝐥𝐚𝐲: 𝐓𝐡𝐞 𝐅𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐁𝐞𝐥𝐠𝐢𝐚𝐧 𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐈𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 🚨 Belgium’s prolonged government formation process has highlighted the complexities of its fragmented political system, with regional governments making strides on health priorities while the federal level remains at an impasse. With coalition negotiations still unresolved, key health reforms and funding decisions are on hold as we approach the end of the year. 🔑 𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬: • 𝐖𝐚𝐥𝐥𝐨𝐨𝐧 & 𝐅𝐥𝐞𝐦𝐢𝐬𝐡 𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭𝐬: Health priorities are known, from reducing waitlists for disability care to strengthening mental health services and addressing environmental health risks. • 𝐁𝐫𝐮𝐬𝐬𝐞𝐥𝐬: Ongoing negotiations risk delaying crucial health policies, especially around equitable access to care. • 𝐅𝐞𝐝𝐞𝐫𝐚𝐥 𝐈𝐦𝐩𝐚𝐬𝐬𝐞: Despite multiple extensions, budget negotiations are stalled, delaying the INAMI budget and vital healthcare reforms like telehealth reimbursement and hospital funding. While the region-focused health strategies are moving forward, the uncertainty at the federal level means that essential health policy decisions—affecting healthcare funding, medical reimbursements, and more—will likely be delayed until a government is finally formed. Check out our full article for the latest updates and what it means for the future of healthcare in Belgium: https://bit.ly/3DnVCaA #Belgium #HealthPolicy #GovernmentFormation #Healthcare

🚨 Save the Date! 🚨 RPP is proud to support the AWARE Alliance and this important conversation on the need to update European legislation to improve the response to sudden cardiac arrests in the workplace. Andras Kulja MD and AWARE will host a discussion at the European Parliament on 13 January 2025, outlining the outdated and insufficient provisions, notably foreseen by the OSH Framework Directive (89/391 EEC) and specifically in the 1989 Directive on workplace requirements (89/654/EEC) on health and safety at work. 📢 The event Creating Cardiac AWAREness at Work: Breathing New Life into the EU Safety at Work Directive will serve to explore solutions for mitigating SCA risks in the workplace. Speakers will advocate for harmonised CPR training, first aid education, and AED availability as solutions. 📊 With only 8% of out-of-hospital cardiac arrest victims surviving in Europe, it is time to act. Studies show that performing bystander CPR can increase survival rates from less than 10% to over 40% for out-of-hospital cardiac arrests. This highlights the urgent need for updated workplace safety policies that include CPR training and equipment availability, ensuring that workers are equipped to respond effectively in such life-threatening situations. Let's create safer, healthier work environments together! 🗓 When: Monday, 13 January 2025, 11:00–13:00  📍 Where: European Parliament, Room ANTALL 6Q1  🎤 Hosted by: MEP Dr. András Kulja 🔗 Scan the QR code or register here to secure your spot in this important discussion! Let's bring #CardiacAwareness to the forefront of workplace health policy. See you there!

📢 Germany’s no-confidence vote confirms elections on February 23, 2025 The German Bundestag has taken a pivotal step, with Chancellor Scholz losing the vote of confidence. This decision confirms early federal elections on 23 February, set to reshape Germany’s political landscape. For organizations, this is a critical moment. Changes in government priorities and leadership will impact policies, regulations, and your strategic goals. Take a look at our brochure to learn how we can help you navigate these developments, engage effectively with policymakers, and stay ahead in a shifting environment. ➡️ Let’s ensure you are prepared for 23 February and beyond. Contact us now to explore our support! #PublicAffairs #Germany #Elections2025 #Scholz Lutz Dommel Alberto Domingo Bayarri Nora Klein Selina Hohensee Emre Uzuner Niklas Burg Kit Greenop Salomé Chelli-Enriquez Kinga Wójtowicz

The Spanish Government has unveiled the Pharmaceutical Industry Strategy 2024-2028, a roadmap designed to bolster access to medicines, foster innovation, and enhance the sector’s strategic autonomy. This interministerial effort, developed with input from industry associations, emphasises sustainability, resilience, and collaboration between public and private stakeholders. Initiatives such as the RECAPI strategic reserve highlight a commitment to secure supply chains and reduce external dependencies.   The strategy reinforces Spain's position as a leader in pharmaceutical innovation and manufacturing, leveraging its status as Europe’s top hub for clinical trials.   Interested in learning how this could open new opportunities? Let's connect—We’re here to provide insights! Lutz Dommel Cristina Fuentes Antrás #RPP #Pharma #Innovation #Health